Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560232 · ClinicalTrials.gov registry record · Phase 4
Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens
A Phase 4 study, sponsored by Mercy Health Ohio.
- Terminated
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT03560232 is a Phase 4 study that was terminated before completion, run by Mercy Health Ohio. The registered enrollment target is 17 participants.
The verdict
NCT03560232, a Phase 4 study, was terminated before completion, sponsored by Mercy Health Ohio.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
To demonstrate noninferiority of three different empiric antimicrobial regimens compared to the traditional antimicrobial regimen for the management of grade III open fractures as well as evaluate outcomes among these groups.
Interventions
- DRUG Ceftriaxone
- DRUG Piperacillin/tazobactam
- DRUG Ampicillin/sulbactam
- DRUG Cefazolin + Gentamicin
- DRUG Clindamycin + Gentamicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-07-09 |
| Est. Completion | 2020-02-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03560232
The ClinicalTrials.gov registry entry for NCT03560232 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mercy Health Ohio, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Ceftriaxone is the first listed.
NCT03560232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03560232 about?
NCT03560232 is a clinical study titled "Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens". To demonstrate noninferiority of three different empiric antimicrobial regimens compared to the traditional antimicrobial regimen for the management of grade III open fractures as well as evaluate outcomes among these groups.
What is the current status of trial NCT03560232?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2018-07-09. Estimated completion is 2020-02-19.
What interventions are being tested in trial NCT03560232?
The interventions under investigation include: Ceftriaxone (DRUG), Piperacillin/tazobactam (DRUG), Ampicillin/sulbactam (DRUG), Cefazolin + Gentamicin (DRUG), Clindamycin + Gentamicin (DRUG).
Who is sponsoring clinical trial NCT03560232?
This trial is sponsored by Mercy Health Ohio, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.